Diabetes Canada 2024 Clinical Practice Guidelines Quick Reference Guide

Zusammenfassung

416569-24 Clinical Practice Guidelines Quick Reference Guide guidelines.diabetes.ca diabetes.ca | 1-800-BANTING (226-8464) UPDATED FOR 2025 How to screen TestResultDysglycemia category A1C (%)† 6.0 – 6.4Prediabetes ≥6.5Diabetes FPG (mmol/L) No caloric intake for at least 8 hours 6.1 – 6.9Impaired Fasting Glucose (IFG) ≥7.0Diabetes Assess risk factors for type 2 diabetes ANNUALLY: • Family history (first-degree relative with type 2 diabetes) • High risk populations (non-white, low socioeco

Kerninformationen

See Diabetes in Older People chapter. Blood Glucose (BG) Targets Fasting / Preprandial BG (mmol/L) 2-hr Postprandial BG (mmol/L) For most people with diabetes4.0 – 7.05.0 – 10.0 If not at A1C ≤7.0 % despite the above BG targets  4.0 – 5.55.0 – 8.0 Continuous Glucose Monitoring (CGM) Targets for...

Clinical priorities may include: Comorbidities • Desired magnitude of A1C, BP, lipid lowering • Side effect profile • Possibility of pregnancy • Access Specific to antihyperglycemic agents: Weight loss • Avoidance of hypoglycemia 1 See Hypertension Canada / Canadian Cardiovascular Society (CC...

Not approved by Health Canada for use in type 1 diabetes 4 See CCS Lipid Guidelines for other warranted therapies. 5 ASA should not routinely be used for the primary prevention of cardiovascular disease in people with diabetes. ASA may be used for secondary prevention. Consider clopidogrel if ASA-...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen